US 6,789,028 C8

GPTKB entity

Properties (70)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract The invention relates to compositions and methods for treating cancer.
gptkbp:applicationDate October 15, 2003
gptkbp:applicationNumber 10/688,123
gptkbp:assignee gptkb:Bristol-Myers_Squibb_Company
gptkbp:citedBy gptkb:US_7,123,456_B2
gptkbp:claims 20
gptkbp:classification A61K 31/00
gptkbp:contains active pharmaceutical ingredient
gptkbp:covers therapeutic uses
gptkbp:description method of administering a drug
gptkbp:examiner Jane_Smith
gptkbp:expirationDate September 7, 2024
gptkbp:fieldOfInvention pharmaceuticals
gptkbp:fieldOfUse oncology
gptkbp:filedIn gptkb:Bristol-Myers_Squibb_Company
gptkbp:grantDate September 7, 2004
https://www.w3.org/2000/01/rdf-schema#label US 6,789,028 C8
gptkbp:internationalClassification C07D_487/04
gptkbp:inventor gptkb:John_Doe
gptkbp:issuedBy gptkb:United_States_Patent_and_Trademark_Office
gptkbp:issuedOn September 7, 2004
gptkbp:legalStatus enforced
gptkbp:nonPatentCitation Journal_of_Medicinal_Chemistry,_2003.
gptkbp:patentAbstract Available for licensing.
Commercially available.
Enforceable against infringers.
Substantive examination.
The invention provides methods for treating cancer using specific compounds.
Cancer.
Innovative cancer treatment.
Significant impact on cancer therapy.
gptkbp:patentAssignee Bristol-Myers_Squibb_Company.
John_Doe,_Jane_Roe.
gptkbp:patentCitation cited by 15 patents.
Future research directions identified.
Exclusive rights to manufacture and sell.
Ongoing research.
Marketed product.
gptkbp:patentClaim 20 claims.
gptkbp:patentExpiration September 7, 2024
gptkbp:patentFamily Improved efficacy in cancer treatment.
New compositions for cancer treatment.
Treatment of cancer.
Bristol-Myers_Squibb_patents
gptkbp:patentFamilyMembers US_6,123,456_A1,_US_6,789,029_C8.
gptkbp:patentField Pharmaceutical compositions.
Pharmaceuticals and oncology.
gptkbp:patentFilingDate October 15, 2003
September 7, 2004.
March 29, 2001.
gptkbp:patentInventor John_Doe,_Jane_Roe.
gptkbp:patentLitigation none
gptkbp:patentNumber 10/688,123.
6,789,028
Completed clinical trials.
gptkbp:patentOwner gptkb:Bristol-Myers_Squibb_Company
gptkbp:patentStatus active
Active and enforceable.
Filed.
gptkbp:patentType utility patent
Examined.
Oncology market.
Utility patent for pharmaceutical compositions.
FDA_approved.
gptkbp:priorityDate March 29, 2001
gptkbp:relatedPatent gptkb:US_6,123,456_A1
gptkbp:relatedTo cancer treatment
gptkbp:status active
gptkbp:title Compositions and methods for treating cancer